← Leaderboards
Janine Maenza
Johns Hopkins University
$56,912
Attributed
$56,912
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $27.7K · FY2005–07$50K$37.5K$25K$12.5K$0
'05
'06
'07
Funding mix
By agency
NIH$56,912 · 5
By mechanism
M01$56,912 · 5
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- John G Bartlett$1,448,360
- Chloe L Thio$13,807,555
- Richard F. Ambinder$9,273,650
- Deborah Persaud$30,632,571
- Andrea Jenay Ruff$102,510,867
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsHuman SubjectClinical ResearchAidsFemaleAntiviral AgentsImmunosuppressionLamivudineHuman Immunodeficiency Virus 1Drug Administration RoutesAids TherapyChemokineAntigen Antibody ReactionClinical Trial Phase ICytokineCachexiaCombination ChemotherapyDiagnosis Design /EvaluationBody WeightDrug Screening /EvaluationAndrogen AnalogHelper T LymphocyteHuman Therapy EvaluationLeukocyte Count
Grant awards (12)
VIROLOGICAL AND IMMUNOLOGICAL EVENTS IN ACUTE/EARLY HIV-1 INFECTION$3,435
M01 · FY2007 · RR · contact PI
VIROLOGICAL AND IMMUNOLOGICAL EVENTS IN ACUTE/EARLY HIV-1 INFECTION$27,712
M01 · FY2006 · RR · contact PI
VIROLOGICAL AND IMMUNOLOGICAL EVENTS IN ACUTE/EARLY HIV-1 INFECTION$25,765
M01 · FY2005 · RR
EFFETCS OF REMUNE AND ANTIVIRAL THERAPY ON HIV 1 SPECIFIC IMMUNOGENICITY$0
M01 · FY2002 · RR
CHRIRON QUANTIPLEX HIV 1 RNA 3 0 ASSAY$0
M01 · FY2002 · RR
TRIAL OF NANDROLONE DECANOATE IN WOMEN WITH HIV CACHEXIA$0
M01 · FY2002 · RR
EFFETCS OF REMUNE AND ANTIVIRAL THERAPY ON HIV 1 SPECIFIC IMMUNOGENICITY$0
M01 · FY2001 · RR
CHRIRON QUANTIPLEX HIV 1 RNA 3 0 ASSAY$0
M01 · FY2001 · RR
TRIAL OF NANDROLONE DECANOATE IN WOMEN WITH HIV CACHEXIA$0
M01 · FY2001 · RR
TRIAL OF NANDROLONE DECANOATE IN WOMEN WITH HIV CACHEXIA$0
M01 · FY2000 · RR
CHRIRON QUANTIPLEX HIV 1 RNA 3 0 ASSAY$0
M01 · FY2000 · RR
EFFETCS OF REMUNE AND ANTIVIRAL THERAPY ON HIV 1 SPECIFIC IMMUNOGENICITY$0
M01 · FY2000 · RR